Loading...
Back to narrative

AnalystConsensusTarget updated the narrative for BG

Update shared on 31 Oct 2025

Fair value Increased 7.43%
n/a
n/a
AnalystConsensusTarget's Fair Value
n/a
Loading
1Y
7.9%
7D
0.7%

Analysts have raised their price target for Bunge Global from $92.78 to $99.67, citing modest improvements in projected revenue growth. This comes despite largely unchanged discount rates and a stable profit margin outlook.

What's in the News

  • Bunge Global SA (NYSE:BG) was dropped from the FTSE All-World Index (USD) (Key Developments)
  • From April 1, 2025 to June 30, 2025, the company repurchased zero shares under its ongoing buyback. The completed repurchase total remains at 19,667,739 shares, or 13.56%, for $1,900.04 million under the buyback program announced on October 27, 2021 (Key Developments)

Valuation Changes

  • Consensus Analyst Price Target has risen from $92.78 to $99.67
  • Discount Rate remains unchanged at 6.78%
  • Revenue Growth is projected to increase slightly, up from 32.90% to 33.53%
  • Net Profit Margin has edged down, falling from 1.89% to 1.87%
  • Future P/E ratio has increased from 12.24x to 13.15x

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.